Itzler, Robbin
Lumry, William R. http://orcid.org/0000-0001-7608-5416
Sears, John
Braverman, Julia
Li, Yinglei
Brennan, Caroline J.
Koch, Gary G.
Funding for this research was provided by:
CSL Behring
Article History
Received: 13 February 2024
Accepted: 8 June 2024
First Online: 22 June 2024
Declarations
:
: Institutional review board approval was not sought because the survey responses were anonymous, and data collected could not be linked to the respondent.
: Not applicable.
: RI was a full-time employee of and owns stocks/options in CSL Behring. JS and JB are full-time employees of and own stocks/options in CSL Behring. CJB was Vice President of Health at Phoenix Marketing International, which was acquired by MarketCast in March 2022, during the period of this study. GGK is a full-time employee of the University of North Carolina at Chapel Hill (UNC-CH), which received funds from CSL Behring through a Collaborative Biostatistics Agreement for his biostatistical activity on their behalf; and UNC-CH has received or is receiving funds from similar agreements for his biostatistical activity with other biopharmaceutical sponsors such as AbbVie, AstraZeneca, BioMarin, Regeneron, and GSK. WRL is or recently was, a speaker, advisor and/or received research funding from the following companies: AstraZeneca, Astria, BioCryst, BioMarin, CSL Behring, GSK, Ionis, Intellia, KalVista, Pharming, Pharvaris, Sanofi/Regeneron, Shire/Takeda; and is a member of the US Hereditary Angioedema Association Medical Advisory Board.